Delivery Order SPE2DR25D1002-SPE2DR26FGK9F
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits valued at $1,139.18, with an ultimate completion date of August 27, 2025. This non-set-aside, firm fixed price delivery order represents a competitively awarded procurement to supply vaccines supporting federal medical supply chain requirements. The contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order valued at $15,660.99 to AmerisourceBergen Drug Corp for Shingrix vial kits. The contract is firm fixed price with no set-aside designation and has an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and holds the place of performance for this award at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,723.40 to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of December 4, 2025. This firm fixed price contract, awarded on December 3, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award utilized no set-aside designation and was competitively...
- The Defense Logistics Agency awarded a delivery order valued at $8,655.43 to AmerisourceBergen Drug Corp for Shingrix vial kits on November 6, 2025, with an ultimate completion date of November 7, 2025. This firm fixed-price contract, which is not set-aside, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be performed at the contractor's...
- The Defense Logistics Agency awarded a $3,417.51 firm fixed price delivery order to AmerisourceBergen Drug Corp for SHINGRIX vial kits, with an ultimate completion date of May 28, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. SHINGRIX, a recombinant zoster vaccine, is a critical preventive health...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits valued at $8,769.12, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,139.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with a completion deadline of July 14, 2025. This competitively awarded contract, issued on July 11, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $7,510.04 to AmerisourceBergen Drug Corp for Shingrix vial kits on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract uses firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with a ceiling value of $1,139.18 and an ultimate completion date of June 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The performance location is also Conshohocken, PA, where AmerisourceBergen maintains its corporate office. This delivery order is issued under...
- The Defense Logistics Agency awarded a $4,556.72 delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of September 25, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award was made to the vendor's corporate office located in Conshohocken, Pennsylvania, serving as the place of performance. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D1002Indefinite Delivery Contract
- SPE2DR25D1002-SPE2DR26FGK9FDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,109.63 to AmerisourceBergen Drug Corp for Shingrix vial kits, with completion targeted for December 9, 2025. This competitively awarded, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used for this award. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's prime IDC vehicle enables it to supply a comprehensive range of pharmaceutical products and medical supplies, including vaccines, specialty medications, and branded and generic drugs across multiple therapeutic domains to support military healthcare programs globally. This delivery order for Shingrix vial kits—a recombinant zoster vaccine—represents routine pharmaceutical fulfillment under this expansive contract framework serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/7/25 |